Calculus Capital invests £2.5m in Axol Bioscience Private equity firm Calculus Capital, a leading EIS and VCT investor, has completed its third deal in two weeks, investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies high quality human cells especially live human … Continued
British men’s shaving supplier Cornerstone has completed a new £3.5m round of investment led by private equity firm Calculus Capital, with e-commerce veteran William Reeve (previously on the boards of Graze, Lovefilm, Zoopla & Paddy Power) joining the Cornerstone top team. Cornerstone – which provides quality British skin care products and German engineered razors to … Continued
Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested in Origin Broadband (Origin), an award-winning provider of internet and phone services. Since Calculus Capital’s first investment in Origin in December 2016, the company has been extremely successful in acquiring new residential customers, surpassing their projected numbers by more than 300%. To … Continued
Calculus Capital are proud to share that portfolio companies, Chop’d and Inspiresport have both been selected as finalists in the Growth Champion of the Year Award, run by Intelligent Partnership. Celebrating the role of the UK SME investment community in job and wealth creation, the Growth Investor Awards recognise those enabling start up and ‘scale up’ businesses to realise … Continued
Calculus Capital portfolio company Premaitha Health Plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing, has announced that it has entered into a further extension of the investment agreement with Thermo Fisher Scientific (“Thermo Fisher”) announced on 14 December 2015 and extended as announced on 23 September 2016, further developing this … Continued
Calculus Capital has been shortlisted for Best EIS Investment Manager at the 2017 Growth Investor Awards, which celebrate the role of the UK’s investment provider community in championing tax-advantaged investments, spotting growth potential and backing outstanding UK small and medium-size enterprises (SMEs). Launched by Intelligent Partnership in 2015, the Growth Investor Awards celebrate the UK’s … Continued
Calculus Capital’s portfolio company Scancell (Scancell Holdings Plc) receives European patent protection for its DNA ImmunoBody technology. Both The Independent and The Telegraph have featured articles on the good news from the British immunology company. The prospect of cancer vaccine moved a step closer on Wednesday after a pioneering British firm announced it had secured … Continued
The Telegraph featured the latest investment round in Blu Wireless Technology, which included the microchip giant ARM Holdings and private equity group Calculus Capital. Blu Wireless is a Bristol-based company whose technology is seen as crucial to the next generation of mobile networks. Blu Wireless’ “millimetre wave” technology increases the amount of data that can … Continued
As featured in The Telegraph on 25/6/17. Calculus Capital, a leading EIS and VCT investor, will invest £2.4 million as a cornerstone investor in a £6.6 million institutional and private investment round into Blu Wireless Technology (“BWT”), a firm leading the way in bringing ultra-fast millimetre Wave (mmWave) wireless technology into homes and businesses through … Continued
Avvio, a world-class booking engine provider for hotels, has announced the launch of a direct booking platform powered by artificial intelligence (AI). The platform, named Allora, is launching in October 2017 and will be the first direct booking platform powered by AI in the world. Allora will give hotels who partner with Avvio an insight … Continued